Inventor · disambiguated record
Mike Tso-Ping Li
Also filed as: LI MIKE · LI MIKE T · LI MIKE TSO-PING
8 granted patents·4 pending applications·87 citations·filing 1995–2021
86Inventor score
Files withKAI PHARMACEUTICALS INC3DEL MAR PHARMACEUTICALS2MATRIX PHARMA2APOLLOMICS INC1DELMAR PHARMACEUTICALS INC1
Top patents by PatentIndex Score
12 records- 0193US7265092B2Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2005·Granted Sep 4, 2007·37 cites·8 claims
- 0292US7727958B2Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2007·Granted Jun 1, 2010·12 cites·9 claims
- 0385US8524673B2Pharmaceutical formulationLI MIKE TSO-PING·Filed 2010·Granted Sep 3, 2013·7 cites·20 claims
- 0469US9029164B2Analytical methods for analyzing and determining impurities in dianhydrogalactitolDEL MAR PHARMACEUTICALS·Filed 2013·Granted May 12, 2015·2 cites·22 claims
- 0563US5980946ACollagen formulationsMATRIX PHARMA·Filed 1997·Granted Nov 9, 1999·17 cites·20 claims
- 0657US5750146ATranslucent collagen formulations with a cytotoxic drugMATRIX PHARMA·Filed 1995·Granted May 12, 1998·12 cites·18 claims
- 0757US2014023632A1Pharmaceutical formulationKAI PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 0852US9630938B2Method of synthesis of substituted hexitols such as dianhydrogalactitolDELMAR PHARMACEUTICALS INC·Filed 2014·Granted Apr 25, 2017·0 cites·27 claims
- 0948US2023338294A1Novel pharmaceutical formulation for c-met inhibitorAPOLLOMICS INC·Filed 2021·Application pending·0 cites
- 1045US9085544B2Method of synthesis of substituted hexitols such as dianhydrogalactitolDEL MAR PHARMACEUTICALS·Filed 2013·Granted Jul 21, 2015·0 cites·28 claims
- 1145US2003171329A1Stable compositions comprising tezacitabineFiled 2003·Application pending·0 cites
- 1243US2009270339A1Unit Dose Form of GlufosfamideLI MIKE·Filed 2007·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →